Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 701–800 of 1,016
El-mayet, F. S., Sawant, L., Thunuguntla, P., & Jones, C. (2017) · Journal of Virology · doi:10.1128/jvi.00904-17 · Cited by 52
Glucocorticoid Excess in Bone and Muscle
Sato, A. Y., Peacock, M., & Bellido, T. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9242-3 · Cited by 57
Carolina, E., Kato, T., Khánh, V. C., Moriguchi, K., Yamashita, T., Takeuchi, K., Hamada, H., & Ohneda, O. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00276 · Cited by 57
“Glucocorticoids (GCs) have been widely used as extremely effective agents for suppressing inflammation associated with various kinds of diseases (1).”
BackgroundHuang, J., Guo, J., Li, H., Huang, W., & Zhang, T.-T. (2019) · Medicine · doi:10.1097/md.0000000000014636 · Cited by 50
Simón‐Vázquez, R., Tsapis, N., Lorscheider, M., Rodríguez, A., Calleja, P., Mousnier, L., Villegas, E. D. M., González‐Fernández, Á., & Fattal, E. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01112-3 · Cited by 55
“Because some of those mechanisms are also involved in physiologic signaling, prolonged use or high doses of GC have significant side effects [41].”
BackgroundInfluentialQuarter-Century Explorations of Bioactive Polyphenols: Diverse Health Benefits
Chu, A. J. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2704134 · Cited by 52
“(a) Endogenous and exogenous glucocorticoids are common anti-inflammatory agents, reducing cytokineinduced genes or mediators [111].”
BackgroundSánchez-Lemus, E., Murakami, Y., Larráyoz, I. M., Moughamian, A. J., Pavel, J., Nishioku, T., & Saavedra, J. M. (2008) · Endocrinology · doi:10.1210/en.2008-0242 · Cited by 58
Corticosteroids influence the mortality and morbidity of acute critical illness
Rady, M. Y., Johnson, D. J., Patel, B., Larson, J., & Helmers, R. (2006) · Critical Care · doi:10.1186/cc4971 · Cited by 48
“Corticosteroids are used therapeutically for relative adrenal insufficiency as well as for the attenuation of the inflammatory and immune response in the critically ill [1].”
BackgroundAvenant, C., Ronacher, K., Stubsrud, E., Louw, A., & Hapgood, J. P. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.007 · Cited by 49
Chandler, L., Yusuf, I., McClements, M., Barnard, A., MacLaren, R., & Xue, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144972 · Cited by 49
“For instance, by inducing expression of the anti-inflammatory molecule mitogen-activated protein kinase (MAPK) phosphatase 1; preventing transcriptional activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) that regulates downstream transcription of a vast range of cytokines; and blocking…”
BackgroundPulmonary drug delivery for acute respiratory distress syndrome
Fei, Q., Bentley, I. D., Ghadiali, S. N., & Englert, J. A. (2023) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2023.102196 · Cited by 55
“Corticosteroids inhibit the action of pro-inflammatory mediators through activation of genes that drive the inflammatory response and suppression of genes that encode anti-inflammatory mediators [11,12].”
BackgroundIFN-γ Reverses IL-2– and IL-4–Mediated T-Cell Steroid Resistance
Goleva, E., Li, L.-B., & Leung, D. Y. M. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0327oc · Cited by 49
“localized to specific domains (1, 2 ). The GCR is localized in the cytoplasm of cells where it forms a”
BackgroundRiccardi, L., Mazzon, E., Bruscoli, S., Esposito, E., Crisafulli, C., Di Paola, R., Caminiti, R., Riccardi, C., & Cuzzocrea, S. (2009) · Shock · doi:10.1097/shk.0b013e31818339e7 · Cited by 48
“Glucocorticoids (GCs), one of the most used drugs to treat IBD patients, exert their anti-inflammatory action through the inhibition of lymphocyte proliferation and synthesis of proinflammatory cytokines and by down-regulating specific adhesion molecules, resulting in redistribution of lymphocyte traffic (5).”
BackgroundKatz, M., & Gans, E. H. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21222 · Cited by 49
Sesti‐Costa, R., Ignacchiti, M. D. C., Chedraoui-Silva, S., Marchi, L. F., & Mantovani, B. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.07.234 · Cited by 53
“The synthetic glucocorticoid used in these treatments binds mainly to GR, and studies have shown that resistance to treatment is due to the inhibition of this receptor (Rhen and Cidlowski, 2005).”
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients
Goleva, E., Jackson, L. P., Gleason, M. C., & Leung, D. Y. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.001 · Cited by 50
“Transcription of proinflammatory cytokines, such as IL-8 and TNF-a, is inhibited by GCR-a through interaction with other transcriptional factors (transrepression).(8,10) GCR-b is a GCR isoform that does not bind steroids, has a distinct set of targets regulated through transcription,(11,12) and has been shown to be in…”
BackgroundInfluentialJangani, M., Poolman, T. M., Matthews, L. C., Yang, N., Farrow, S. N., Berry, A. A., Hanley, N. A., Williamson, A. J. K., Whetton, A. D., Donn, R. P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540906 · Cited by 55
Ultradian Cortisol Pulsatility Encodes a Distinct, Biologically Important Signal
McMaster, A., Jangani, M., Sommer, P., Han, N., Brass, A., Beesley, S., Lu, W., Berry, A., Loudon, A., Donn, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015766 · Cited by 48
“The activated GR can either bind directly to target DNA sequences, or via a tethering mechanism to other, DNA-bound transcription factors, including NFkB, AP-1, HNF4, C/EBP and ets [18,23,24].”
BackgroundBileck, A., Kreutz, D., Muqaku, B., Slany, A., & Gerner, C. (2014) · Journal of Proteome Research · doi:10.1021/pr5008625 · Cited by 49
Conteduca, V., Crabb, S. J., Jones, R. J., Caffo, O., Elliott, T., Scarpi, E., Fabbri, P., Derosa, L., Massari, F., Numico, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158952 · Cited by 53
“Unlike some other key drugs for PC, enzalutamide is not co-administered with corticosteroids, which may alter NLR due to the accelerated release of neutrophils from the bone marrow into the circulation [18, 19].”
BackgroundHow can we minimise the use of regular oral corticosteroids in asthma?
BOURDIN, A. A., Adcock, I. M., Berger, P., Bonniaud, P., Chanson, P., Chenivesse, C., Jacques de, B. L. I. C., Deschildre, A., Devillier, P., Devouassoux, G., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0085-2019 · Cited by 53
Jiao, T., Yao, X., Zhao, Y.-Y., Zhou, Y., Gao, Y., Fan, S., Chen, P., Li, X., Jiang, Y., Xiao, Y., et al. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000061 · Cited by 52
“, rheumatic arthritis, asthma, allergy, and transplantation rejection) (Rhen and Cidlowski, 2005; Ericson-Neilsen and Kaye, 2014).”
BackgroundLee, A., & Blair, H. A. (2020) · Drugs · doi:10.1007/s40265-020-01344-6 · Cited by 49
Fucoxanthin rescues dexamethasone induced C2C12 myotubes atrophy
Zhiyin, L., Jinliang, C., Qiunan, C., Yunfei, Y., & Xiao, Q. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111590 · Cited by 54
Indraswari, F., Wang, H., Lei, B., James, M. L., Kernagis, D., Warner, D. S., Dawson, H. N., & Laskowitz, D. T. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2117 · Cited by 50
“Nr3c1, a glucocorticoid receptor, induces expression of anti-inflammatory genes (Rhen and Cidlowski, 2005).”
Gründemann, C., Garcia‐Käufer, M., Sauer, B., Stangenberg, E., Könczöl, M., Merfort, I., Zehl, M., & Huber, R. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.10.039 · Cited by 53
Etomidate increases susceptibility to pneumonia in trauma patients
Asehnoune, K., Mahe, P. J., Séguin, P., Jaber, S., Jung, B., Guitton, C., Chatel-Josse, N., Subileau, A., Tellier, A. C., Masson, F., et al. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2619-8 · Cited by 54
“With respect to glucocorticoid therapy, high-dose methylprednisolone and low-dose hydrocortisone display different effects on the immune response [35], and while the former’s regimen is immunosuppressive and induces apoptosis of numerous immune cells [36, 37], hydrocortisone acts as an immunomodulatory drug [34].”
BackgroundRobert, O., Boujedidi, H., Bigorgne, A., Ferrere, G., Voican, C. S., Vettorazzi, S., Tuckermann, J. P., Bouchet‐Delbos, L., Tran, T., Hémon, P., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.023 · Cited by 48
“GCs display strong anti-inflammatory properties, via activation of the GR [25].”
Backgroundvan den Munckhof, B., de Vries, E. E., Braun, K. P. J., Boss, H. M., Willemsen, M. A. A. P., van Royen‐Kerkhof, A., de Jager, W., & Jansen, F. E. (2015) · Epilepsia · doi:10.1111/epi.13274 · Cited by 48
Brownlow, M., DART, A., & Jeffcott, L. B. (2016) · Australian Veterinary Journal · doi:10.1111/avj.12454 · Cited by 55
Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay
Block, T. S., Murphy, T., Münster, P. N., Nguyen, D., & Lynch, F. J. (2017) · Cancer Management and Research · doi:10.2147/cmar.s124475 · Cited by 50
Fechtner, S., Singh, A., Srivastava, I., Szlenk, C. T., Muench, T. R., Natesan, S., & Ahmed, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01027 · Cited by 52
“Glucocorticoids mainly elicit their anti-inflammatory effects by interfering with pro-inflammatory transcription factors AP1 or NF-κB from transcribing pro-inflammatory mediators, but other mechanisms of action for glucocorticoids are also described (34, 47).”
BackgroundKertser, A., Baruch, K., Deczkowska, A., Weiner, A., Croese, T., Kenigsbuch, M., Cooper, I., Tsoory, M., Ben-Hamo, S., Amit, I., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4111 · Cited by 48
“Such a response, if persists, can cause suppressive effects on peripheral immune responses (3, 4).”
BackgroundThe Biology of Social Adversity Applied to Oral Health
Gomaa, N. A., Tenenbaum, H. C., Glogauer, M., & Quiñonez, C. (2019) · Journal of Dental Research · doi:10.1177/0022034519876559 · Cited by 56
“…innate immune cell functions and chronic allergic reactions, thus exerting an antiinflammatory effect on immune cells by inhibiting proinflammatory signaling pathways, reducing cell-cell adhesion, and impairing circulating neutrophil function (e.g., superoxide generation; Rhen and Cidlowski 2005).”
BackgroundCediel-Ulloa, A., Gliga, A. R., Love, T., Pineda, D., Mruzek, D. W., Watson, G. E., Davidson, P. W., Shamlaye, C. F., Strain, J., MYERS, G. J., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.106321 · Cited by 50
“Lower levels of the glucocorticoid receptor would result in lower responsiveness to cortisol and other glucocorticoids, whose functions include decreasing inflammation and regulating stress responses (Rhen and Cidlowski 2005; Binder 2009).”
Perioperative glucocorticoid management based on current evidence
Seo, K. H. (2021) · Anesthesia and Pain Medicine · doi:10.17085/apm.20089 · Cited by 51
“In addition, continuous glucocorticoid administration results in sodium retention, subsequent plasma volume increase, and intensifies vasopressor response to angiotensin II and catecholamines, leading to hypertension [32].”
BackgroundÖzsürekçi, Y., Gürlevik, S. L., Kesici, S., Akça, Ü. K., Oygar, P. D., Aykaç, K., Karacanoğlu, D., Nakip, Ö. S., İlbay, S., Katlan, B., et al. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05631-9 · Cited by 49
“Lifethreatening situations due to cytokine storm could be downregulated by corticosteroids [34].”
BackgroundKook, I., Henley, C., Meyer, F., Hoffmann, F. G., & Jones, C. (2015) · Virology · doi:10.1016/j.virol.2015.06.010 · Cited by 48
“Since the mammalian GR and corticosteroid signaling pathways are highly conserved (Oakley and Cidlowski, 2013; Rhen and Cidlowski, 2005), the use of a mouse GR was appropriate.”
BackgroundMethodInfluentialMode of Glucocorticoid Actions in Airway Disease
Ito, K., Getting, S., & Charron, C. E. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.274 · Cited by 54
“Glucocorticoids exert their effects by binding to a single 777-amino-acid glucocorticoid receptor (GR) that is localized to the cytoplasm of almost all cell types[20,21].”
BackgroundBeaudry, J. L., D'souza, A. M., Teich, T., Tsushima, R., & Riddell, M. C. (2013) · Endocrinology · doi:10.1210/en.2012-2114 · Cited by 45
“Exogenous glucocorticoids (GCs) can have acute beneficial outcomes for the treatment of some inflammatory conditions (1), however, they are associated with widespread metabolic effects that have the potential to deteriorate glucose homeostasis.”
BackgroundCurrent and future treatments for Behçet’s uveitis: road to remission
Mesquida, M., Molins, B., Llorenç, V., Hernández, M. V., Espinosa, G., Dick, A., & Adán, A. (2014) · International ophtalmology · doi:10.1007/s10792-013-9788-5 · Cited by 49
“They are often used orally at high doses (prednisone, 1 mg/kg/day) or even endovenously (methylprednisolone, 500 mg/day for three consecutive days) to treat the sight-threatening ocular attack [18, 19], followed by a gradual tapering by 5–10 mg/week.”
BackgroundIncreased Adiposity in Annexin A1-Deficient Mice
Akasheh, R. T., Pini, M., Pang, J., & Fantuzzi, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082608 · Cited by 56
“An additional GC-regulating pathway potentially involved in obesity is the enzyme 11bHSD1, which regulates intracellular levels of corticosterone [25].”
BackgroundConsenso sobre el diagnóstico y tratamiento de la sordera subita
Plaza, G., Durio, E., Herráiz, C., Rivera, T., & García‐Berrocal, J. R. (2010) · Acta Otorrinolaringológica Española · doi:10.1016/j.otorri.2010.09.001 · Cited by 60
Ituk, U. S., & Thenuwara, K. N. (2018) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2018.03.008 · Cited by 47
Palma-Gudiel, H., Prather, A. A., Lin, J., Oxendine, J. D., Guintivano, J., Xia, K., Rubinow, D. R., Wolkowitz, O., Epel, E. S., & Zannas, A. S. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.027 · Cited by 43
“The hypothalamic-pituitary-adrenal (HPA) axis is a highly conserved neuroendocrine axis in vertebrates that modulates multiple physiological processes, including stress responses and immune function (Chrousos and Gold, 1992; Horowitz and Zunszain, 2015; Rhen and Cidlowski, 2005).”
BackgroundAdvances in understanding of Netherton syndrome and therapeutic implications
Petrova, E., & Hovnanian, A. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1857724 · Cited by 51
Lee, F. E.-H., Walsh, E. E., Falsey, A. R., Lumb, M. E., Okam, N. V., Liu, N., Divekar, A., Hall, C. B., & Mosmann, T. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/518249 · Cited by 47
Howell, M. P., & Muglia, L. J. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.05.001 · Cited by 46
Medical treatment of Rasmussen's Encephalitis: A systematic review
Lagarde, S., Boucraut, J., & Bartoloméi, F. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.01.007 · Cited by 49
Vollmer, T. R., Stockhausen, A., & Zhang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400671 · Cited by 51
“While glucocorticoids as a class of potent anti-inflammatory drugs continue to be used formany inflammatory diseases, the application of glucocorticoids is limited by their side effects (41).”
BackgroundInfluentialInnate immunity in type 1 diabetes
Zipris, D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1256 · Cited by 49
“IκB and mitogen-activated protein kinase phosphatase) or directly modulate the function of signalling molecules involved in inflammation [41,42].”
BackgroundMetabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in Humans
Hughes, S. C., Shardlow, P. C., Hollis, F. J., Scott, R. J., Motivaras, D. S., Allen, A., & Rousell, V. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022137 · Cited by 46
“Agonism of the glucocorticoid receptor is known to suppress the activation of downstream transcription factors, such as NF- B and activation protein-1, and to activate the glucocorticoid response element transactivation pathway (Rhen and Cidlowski, 2005).”
BackgroundAndalib, A., Aminian, A., Khorgami, Z., Jamal, M. H., Augustin, T., Schauer, P. R., & Brethauer, S. A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1923-0 · Cited by 46
Wang, W.-C., Xia, Y., Yang, B., Su, X., Chen, J.-K., Li, W., & Jiang, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00756 · Cited by 48
A severe mouse model of spinal muscular atrophy develops early systemic inflammation
Wan, B., Feng, P., Guan, Z., Sheng, L., Liu, Z., & Hua, Y. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy300 · Cited by 53
Deng, J., Chalhoub, N. E., Sherwin, C. M. T., Li, C., & Brunner, H. I. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.03.010 · Cited by 48
Mussini, C., Falcone, M., Nozza, S., Sagnelli, C., Parrella, R., Meschiari, M., Petrosillo, N., Mastroianni, C. M., Cascio, A., Iaria, C., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.12.011 · Cited by 48
“Glucocorticosteroids act as a wider immunemodulator than the single cytokine blockers [57,58].”
BackgroundBrief review on repurposed drugs and vaccines for possible treatment of COVID-19
De, P., Chakraborty, I., Karna, B., & Mazumder, N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173977 · Cited by 51
Hu, X., Pang, J., Zhang, J., Shen, C., Chai, X., Wang, E., Chen, H., Wang, X., Duan, M., Fu, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202102435 · Cited by 50
Glucocorticoids for peri‐operative analgesia: how far are we from general recommendations?
Kehlet, H. (2007) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2007.01459.x · Cited by 46
“The finding of a reduced fatigue response using a smaller glucocorticoid dose (8 mg dexametazone) has also been shown in cholecystectomy (10) and may be related to a reduced interleukin-6 (IL-6) and C reactive protein (CRP) response (1, 4, 10).”
BackgroundRole of STAT3 in glucocorticoid-induced expression of the human IL-10 gene
Unterberger, C., Staples, K. J., Smallie, T., Williams, L. M., Foxwell, B. M. J., Schaefer, A. E., Kempkes, B., Hofer, T. P. J., Koeppel, M., Lohrum, M. A. E., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.02.020 · Cited by 53
“On the other hand GC will act by binding to and interfering with the action of other transcription factors 6 like NF-kB (Rhen and Cidlowski, 2005), which will lead to suppression of genes like the pro-inflammatory Tumor Necrosis Factor.”
Volovitz, B. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.10.009 · Cited by 46
“Such an approach would be especially valuable in acute severe asthma.38 The high dose effects may involve non-genomic effect of inhaled steroids as recently suggested by Horvath and Wanner39 and Rhen and Cidlowsky.40 These effects may be more rapid than those corticosteroid effects than involve genomic transcription,…”
BackgroundGlucocorticoid Effects on Adiponectin Expression
Sukumaran, S., DuBois, D. C., Jusko, W. J., & Almon, R. R. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00007-5 · Cited by 49
“In addition, GCs are potent antiinflammatory agents and cause reduction in proinflammatory cytokines, which again can indirectly regulate adiponectin expression (Barnes, 1998; Rhen & Cidlowski, 2005).”
Porcu, G., Serone, E., Nardis, V. D., Giandomenico, D. D., Lucisano, G., Scardapane, M., Poma, A. M., & Ragnini‐Wilson, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144550 · Cited by 48
“Methylprednisolone is widely used as an anti-inflammatory drug to treat a wide range of human pathological conditions of the CNS consequent to autoimmune attacks, including MS [4, 72].”
BackgroundLung Inflammation in ARDS — Friend or Foe?
Suter, P. M. (2006) · New England Journal of Medicine · doi:10.1056/nejme068033 · Cited by 46
Dexamethasone: A boon for critically ill COVID-19 patients?
Patel, S. K., Saikumar, G., Rana, J., Dhama, J., Yatoo, M. I., Tiwari, R., Rodriguez-Morales, A. J., & Dhama, K. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101844 · Cited by 45
Adjuvant analgesics in acute pain
Lui, F., & Ng, K.-F. J. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.521743 · Cited by 45
“Glucocorticoids inhibit prostaglandin production by induction and activation of annexin, induction of MAPK phosphatase, and suppressing cyclooxygenase-2 transcription [76].”
BackgroundMultiscale model for the assessment of autonomic dysfunction in human endotoxemia
Foteinou, P. T., Calvano, S. E., Lowry, S. F., & Androulakis, I. P. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00184.2009 · Cited by 49
The hypothalamic–pituitary–adrenal axis in critical illness
Venkataraman, S. T., Munoz, R. A., Cândido, C., & Witchel, S. F. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9058-9 · Cited by 51
“Glucocorticoids decrease expression of the phospholipase A2, cyclooxygenase 2 (COX2), prostaglandin synthase 2 (PGS2), iNOS (NOS2), IL-12, IL-6, and IL-1β genes [26, 27].”
BackgroundCheng, Q., Morand, E. F., & Yang, Y. H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00169 · Cited by 51
“…by tethering to and interfering with the function of proinflammatory transcription factors, such as NF-κB and AP-1, which consequently results in repression of a large number of proinflammatory mediators, cytokines, chemokines and adhesion molecules (Rhen and Cidlowski, 2005; Nixon et al., 2013).”
BackgroundInfluentialPazdrak, K., Straub, C., Maroto, R., Stafford, S. J., White, W. I., Calhoun, W. J., & Kurosky, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601029 · Cited by 49
“The anti-inflammatory effects of GCs are mediated through the GCR, which acts mainly via genomic mechanisms (12).”
BackgroundCorcoran, T. B., Kasza, J., Short, T. G., O’Loughlin, E., Chan, M. T. V., Leslie, K., Forbes, A. B., Paech, M. J., & Myles, P. S. (2016) · British Journal of Anaesthesia · doi:10.1093/bja/aew446 · Cited by 47
Ho, Y., Lee, S., Yang, M., Liu, R. H., Lee, C., Li, Y.-C., & Kuan, Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.017 · Cited by 45
“Glucocorticoid is an anti-inflammatory agent and the only effective therapeutic agent for ALI, while adverse effects, which such as headache, increasing body weight, muscle weakness, fatigue, sick feeling, and osteoporosis, limit its use [23].”
BackgroundLédée, N., Prat-Ellenberg, L., Petitbarat, M., Chevrier, L., Simon, C., Irani, E. E., Vitoux, D., Bensussan, A., & Chaouat, G. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.03.003 · Cited by 45
Harrison, K. S., Zhu, L., Thunuguntla, P., & Jones, C. (2019) · Journal of Virology · doi:10.1128/jvi.00418-19 · Cited by 46
“Since corticosteroids have anti-inflammatory and immunosuppressive properties (30, 31), GrNesCre mice may be very susceptible to virulent HSV-1 strains, including McKrae.”
BackgroundTihista, M. C., Gu, A., Wei, C., Weinreb, J. H., & Rao, R. D. (2020) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2020.04.010 · Cited by 47
Liposomal Nanotherapy for Treatment of Atherosclerosis
Darwitan, A., Wong, Y. S., Nguyen, L. T. H., Czarny, B., Vincent, A., Nedumaran, A. M., Tan, Y., Muktabar, A., Tang, J. K., Ng, K. W., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000465 · Cited by 45
Raloxifene as a treatment option for viral infections
Hong, S., Chang, J., Jeong, K., & Lee, W. (2021) · The Journal of Microbiology · doi:10.1007/s12275-021-0617-7 · Cited by 52
Abdou, R. M., El-Maadawy, W. H., Hassan, M. N. M., El-Dine, R. S., Aboushousha, T., El-Tanbouly, N. D., & El-Sayed, A. M. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113939 · Cited by 48
Cystoid Macular Edema in Uveitis
de Smet, M. D., & Okada, A. A. (2010) · Developments in ophthalmology · doi:10.1159/000320077 · Cited by 45
Small-Molecule Suppressors of Cytokine-Induced β-Cell Apoptosis
Chou, D. H., Bodycombe, N. E., Carrinski, H. A., Lewis, T. A., Clemons, P. A., Schreiber, S. L., & Wagner, B. K. (2010) · ACS Chemical Biology · doi:10.1021/cb100129d · Cited by 52
Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies
Martínez-Ramos, S., Rafael‐Vidal, C., Pego‐Reigosa, J. M., & García, S. (2022) · Cells · doi:10.3390/cells11030515 · Cited by 49
“These transcription factors promote the expression of anti-inflammatory mediators [120] and inhibit the expression of inflammatory mediators, including prostaglandins (departing from COX2 transcription blocking) [119,121] and Phospholipase A2 in the arachidonic acid pathway [122].”
BackgroundCaffarelli, C., Calcinai, E., Rinaldi, L., Dascola, C. P., Terracciano, L., & Corradi, M. (2012) · Respiration · doi:10.1159/000341969 · Cited by 44
Targeting Dexamethasone to Macrophages in a Porcine Endotoxemic Model
Granfeldt, A., Hvas, C. L., Graversen, J. H., Christensen, P. A., Petersen, M. D., Anton, G., Svendsen, P., Sølling, C. G., Etzerodt, A., Tønnesen, E., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828a45ef · Cited by 44
“Glucocorticoids exert pronounced alleviating effects on inflammation and have been extensively used to treat both chronic and acute inflammatory conditions (1).”
BackgroundBerce, V., Kozmus, C. P., & Potočnik, U. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.36 · Cited by 47
Na, H., Park, J., Lee, H. G., Lee, H. N., Myung, S., & Surh, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.005 · Cited by 47
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Patel, G. C., Millar, J. C., & Clark, A. F. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26383 · Cited by 45
“medications worldwide because of their broad spectrum of antiinflammatory and immunomodulatory activities.(2,3) Therapeutic GCs are prescribed to approximately 1.”
BackgroundBenefit:Risk Profile of Budesonide in Obstructive Airways Disease
Tashkin, D. P., Lipworth, B. J., & Brattsand, R. (2019) · Drugs · doi:10.1007/s40265-019-01198-7 · Cited by 46
Autonomic dysfunction and cardiovascular risk in post-traumatic stress disorder
Fu, Q. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102923 · Cited by 49
Gupta, S. K., Prasanth, K., Chen, C., & Yeh, T. F. (2011) · International Journal of Pediatrics · doi:10.1155/2012/315642 · Cited by 44
“In addition, glucocorticoids also suppress both cyclooxygenase I and II similar to NSAID, potentiating the anti-inflammatory effect [7].”
BackgroundFactors that influence Tolosa–Hunt syndrome and the short-term response to steroid pulse treatment
Zhang, X., Zhang, W., Liu, R., Dong, Z., & Yu, S. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.031 · Cited by 44
“Glucocorticoids inhibit the inflammatory mediators that underlie pain signals [20] and our results may reflect the potent impact of steroids on themechanisms that underlie pain and to a lesser degree the potentially more complex mechanisms underlying nerve palsy.”
Owens, C. D., Gasper, W. J., Walker, J. P., Alley, H. F., Conte, M. S., & Grenon, S. M. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.10.051 · Cited by 45
“Dexamethasone induces the anti-inflammatory proteins annexin 1 and mitogen-activated kinase phosphatase 1 while repressing the transcription of proinflammatory molecules such as cyclooxygenase 2.(34) Dexamethasone also markedly inhibits the production of reactive oxygen species by mononuclear cells and polymorphonucle…”
米本崇子, Masuzaki, H., Yasue, S., Okada, S., Kozuka, C., Tanaka, T., Noguchi, M., Tomita, T., Fujikura, J., Yamamoto, Y., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00320.2009 · Cited by 47
Metabolic correlations of glucocorticoids and polyamines in inflammation and apoptosis
Bjelaković, G., Stojanović, I. R., Jevtović−Stoimenov, T., Pavlovic, D. D., Kocic, G. M., Rossi, S., Tabolacci, C., Nikolić, J., Sokolovic, D. T., & Bjelaković, L. (2010) · Amino Acids · doi:10.1007/s00726-010-0489-3 · Cited by 45
“The current scientific knowledge indicates that the GC inhibit inflammation through all three mechanisms: direct genomic, indirect genomic and no-genomic effects (Elenkov and Chrousos 2002; Iuchi et al. 2003; Schäfer et al. 2005; Rhen and Cildowski 2005).”
InfluentialFeng, Y., Lu, S., Wang, J., Kumar, P., Zhang, L., & Bhatt, A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.073 · Cited by 43
Ren, K., Yuan, H., Zhang, Y., Wei, X., & Wang, D. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.027 · Cited by 43
Acute Stress Elicited by Bungee Jumping Suppresses Human Innate Immunity
van Westerloo, D. J., Choi, G., Löwenberg, E. C., Truijen, J., de Vos, A. F., Endert, E., Meijers, J. C. M., Zhou, L., Pereira, M. P. F. L., Queiroz, K. C. S., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00204 · Cited by 42
Diaz, J., Warren, L., Helfner, L., Xue, X., Chatterjee, P. K., Gupta, M., Solanki, M., Esposito, M., Bonagura, V. R., & Metz, C. N. (2015) · Immunologic Research · doi:10.1007/s12026-015-8717-2 · Cited by 48
“In contrast, GRb directly binds DNA to block glucocorticoid–GRa interactions and thus serves to inhibit glucocorticoid action [64].”
BackgroundUpdate on lung transplantation: programmes, patients and prospects
Kotsimbos, T. C., Williams, T. J., & Anderson, G. P. (2012) · European Respiratory Review · doi:10.1183/09059180.00006312 · Cited by 48
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.